Profile
OS Fund is a venture capital firm based in Chicago, Illinois, founded in 2014 by Bryan Johnson. The firm focuses on investing in platforms and enabling technologies that support inventors and scientists in building programmable-biology solutions. With a small team, OS Fund is dedicated to rewriting the operating systems of life to benefit humanity.
The firm invests in sectors such as genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. OS Fund typically invests in pre-seed, seed, and Series A stages, with an average check size of $1-2 million. Their investments are primarily focused in the United States.
Notable investments by OS Fund include Arzeda - biotechnology, Kenota Health - diagnostic equipment, A-Alpha Bio - drug discovery, Pre Brands - food products, and Strateos - laboratory services. These investments highlight OS Fund's commitment to advancing life sciences and technology.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.